Monday, June 27, 2016

BRIEF-Xencor enteres into collaboration and license agreement with Novartis

* Xencor announces strategic collaboration for bispecific

programs, including XMAB 14045 and XMAB 13676

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)